Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III StudyHans von der Maase, PierFranco Conte, Pierre Kerbrat et al.|Journal of Clinical Oncology|2000Cited by 2.3k
Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder CancerHans von der Maase, M. Arning, Lisa Sengeløv et al.|Journal of Clinical Oncology|2005Cited by 1.9k
Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trialR.T.D. Oliver, SP Stenning, MD Mason et al.|The Lancet|2005Cited by 447
Impact of Immune Parameters on Long-Term Survival in Metastatic Renal Cell CarcinomaFrede Donskov, Hans von der Maase|Journal of Clinical Oncology|2006Cited by 308
Monocytes and neutrophils as ‘bad guys’ for the outcome of interleukin-2 with and without histamine in metastatic renal cell carcinoma – results from a randomised phase II trialFrede Donskov, Hans von der Maase|British Journal of Cancer|2006Cited by 71